-+ 0.00%
-+ 0.00%
-+ 0.00%

REZOLUTE, - FDA STILL REVIEWING SUBMISSION FOR REGULATORY PATH FORWARD FOR ERSODETUG IN CONGENITAL HI

路透·09/09/2026 11:00:02

登录查看新闻详情